Interestingly, inhibitory immune molecules, including programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1), which block CD8+ T cell-mediated tumor cell clearance, are highly expressed in MCC samples, particularly at the tumor periphery [79,80,81,87]. The gene discussed is CD8A; the disease is neoplasm.